News
Study identifies molecular drivers of drug resistance in HER2-positive breast cancer
8+ hour, 33+ min ago (615+ words) The study provides a framework for identifying resistance-associated biomarkers that may be useful for patient stratification or therapeutic targeting. Breast cancer is the most commonly diagnosed cancer worldwide, with more than 2.3 million new cases reported each year. Roughly 15 to 20 percent…...